CME
CME Group Inc
CME Group Inc historical holders
total: 10
US Equity Fund CME Group Inc transactions over time
- Total transactions:
- 6
- New positions:
- 1
- Sold out:
- 1
- Added:
- 1
- Reduced:
- 3
- Held since:
- 2020 Q4
- Held for:
- 5 quarters
- Latest activity:
- 2022 Q1
Independent Franchise Partners has been an institutional investor in CME Group Inc (CME) since 2020 Q4. According to 2026 Q1 report, Independent Franchise Partners doesn't hold any shares. The fund/company first acquired CME in 2020 Q4, initially purchasing 205,578 shares. Since the initial investment, US Equity Fund has made 5 more transactions in this position.
When did Independent Franchise Partners exit their CME position?
Independent Franchise Partners no longer holds CME Group Inc (CME). They sold off their entire position in 2022 Q1, closing out an investment that began in 2020 Q4.
When did Independent Franchise Partners first invest in CME?
Independent Franchise Partners first invested in CME Group Inc (CME) in 2020 Q4 at the reported quarter-end price of $182.05 per share, acquiring 205,578 shares in their initial purchase.
What is Independent Franchise Partners's average cost basis for CME?
Based on historical transaction data, Independent Franchise Partners's estimated cost basis for CME Group Inc (CME) is approximately $182.11 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $182.11
- Weighted AVG sell price:
- $227.75
CME transactions history by US Equity Fund
6 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q1
|
0.00%
|
0
|
$228.46
|
|
-100% (-201,458)
|
-2.21%
|
|
2021 Q4
|
2.21%
|
201,458
|
$228.46
|
$46,025,095
|
-0.06% (-127)
|
-0%
|
|
2021 Q3
|
1.95%
|
201,585
|
$193.38
|
$38,982,507
|
-1.90% (-3,905)
|
-0.04%
|
|
2021 Q2
|
2.16%
|
205,490
|
$212.68
|
$43,703,613
|
-0.31% (-635)
|
-0.01%
|
|
2021 Q1
|
2.19%
|
206,125
|
$204.23
|
$42,096,909
|
+0.27% (+547)
|
+0.01%
|
|
2020 Q4
|
2.03%
|
$182.05
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.